Viatris
- Market cap
- 20.09B
- P/E (TTM)i
- -47.27
- P/Bi
- 1.41
- EPSi
- -3.00
- Div yieldi
- 2.74%
- 52W posi
- 90%
Anonymous reader poll. Unscientific, not investment advice.
About Viatris
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
- Founded
- 2019
- CEO
- Mr. Scott A. Smith
- Employees
- 30,000
- Headquarters
- Canonsburg, Pennsylvania, United States of America
- Fiscal year end
- 12-31
- Website
- viatris.com
Company profile
- Exchange
- US
- Symbol
- VTRS
- Market-cap rank
- #916
- Listing date
- 1970-01-01
- Market cap
- 20.09B
- Float cap
- 19.97B
- Shares out
- 1.15B
- Float shares
- 1.14B
Sectors & themes
Quote time 2026-10-08 07:00:16 · For reference only, not investment advice and not tailored to your situation.